HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Erik S G Stroes Selected Research

Secondary Prevention

9/2012Intervention to improve adherence to lipid-lowering medication and lipid-levels in patients with an increased cardiovascular risk.
2/2008High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Erik S G Stroes Research Topics

Disease

71Cardiovascular Diseases (Cardiovascular Disease)
01/2024 - 12/2002
45Atherosclerosis
02/2024 - 03/2004
37Inflammation (Inflammations)
01/2024 - 04/2005
27Coronary Artery Disease (Coronary Atherosclerosis)
04/2024 - 10/2004
25Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
04/2024 - 12/2002
16Atherosclerotic Plaque (Atheroma)
01/2024 - 02/2006
11Aortic Valve Stenosis (Aortic Stenosis)
03/2023 - 01/2019
10Myocardial Infarction
12/2023 - 02/2012
10Neoplasms (Cancer)
11/2023 - 07/2007
8Hypercholesterolemia
11/2023 - 04/2007
8Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2020 - 01/2009
7Pancreatitis
04/2024 - 03/2018
7Type 2 Diabetes Mellitus (MODY)
11/2023 - 11/2007
7Coronary Disease (Coronary Heart Disease)
10/2020 - 12/2009
6Stroke (Strokes)
12/2023 - 02/2012
6Rheumatoid Arthritis
01/2022 - 06/2007
6Injection Site Reaction
01/2021 - 08/2007
5Hyperlipoproteinemia Type I (Lipoprotein Lipase Deficiency, Familial)
04/2024 - 01/2019
5Pathologic Constriction (Stenosis)
02/2024 - 09/2005
5Hypertension (High Blood Pressure)
10/2022 - 12/2001
4Inborn Genetic Diseases (Disease, Hereditary)
04/2024 - 01/2019
4Hypertriglyceridemia
02/2024 - 12/2014
4Aortic Valve Disease
11/2023 - 01/2020
4Homozygous Familial Hypercholesterolemia
07/2023 - 08/2013
4Disease Progression
01/2023 - 01/2019
4Body Weight (Weight, Body)
12/2020 - 05/2007
4Carotid Artery Diseases
10/2020 - 04/2008
4Obesity
09/2018 - 09/2008
4Hypoalphalipoproteinemias (Hypoalphalipoproteinemia)
12/2014 - 06/2003
4Hyperplasia
09/2005 - 02/2004
3Hypotension (Low Blood Pressure)
11/2023 - 10/2007
3Hyperlipoproteinemia Type III (Broad Beta Disease)
09/2023 - 01/2017
3Dyslipidemias (Dyslipidemia)
02/2023 - 07/2007
3Hereditary Angioedemas
01/2023 - 12/2008
3Peripheral Arterial Disease
01/2022 - 12/2013
3Arteritis
01/2021 - 10/2014
3Chronic Disease (Chronic Diseases)
01/2020 - 12/2012
3Insulin Resistance
10/2017 - 07/2007
3Thrombosis (Thrombus)
08/2016 - 07/2009
3Vascular Diseases (Vascular Disease)
01/2013 - 07/2007
2Ischemia
02/2024 - 12/2001
2Ischemic Stroke
12/2021 - 01/2021
2Chronic Renal Insufficiency
01/2021 - 01/2017
2Angioedema
01/2020 - 04/2019
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2020 - 04/2006
2Myocardial Ischemia (Ischemic Heart Diseases)
12/2019 - 06/2007

Drug/Important Bio-Agent (IBA)

37LipidsIBA
01/2024 - 06/2004
36LDL CholesterolIBA
04/2024 - 06/2004
36Lipoprotein(a)IBA
01/2024 - 06/2004
27oxidized low density lipoproteinIBA
01/2024 - 02/2007
27Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2024 - 12/2002
23Triglycerides (Triacylglycerol)IBA
04/2024 - 06/2004
23HDL CholesterolIBA
11/2023 - 06/2004
17CholesterolIBA
01/2024 - 06/2004
17Lipoproteins (Lipoprotein)IBA
09/2023 - 06/2004
15Biomarkers (Surrogate Marker)IBA
03/2023 - 12/2002
14C-Reactive ProteinIBA
03/2023 - 06/2004
11Apolipoproteins B (ApoB)IBA
01/2021 - 05/2007
11ApolipoproteinsIBA
01/2019 - 05/2007
9HDL LipoproteinsIBA
12/2022 - 05/2007
9Apolipoprotein A-I (Apolipoprotein A1)IBA
01/2019 - 10/2004
8LDL Lipoproteins (beta Lipoproteins)IBA
11/2023 - 02/2007
8Proteins (Proteins, Gene)FDA Link
01/2023 - 12/2010
6ISIS 304801IBA
02/2024 - 01/2019
6Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
12/2022 - 10/2016
6mipomersenIBA
11/2014 - 05/2010
5Apolipoprotein C-IIIIBA
04/2024 - 12/2014
5evolocumabIBA
09/2023 - 10/2017
5Glucose (Dextrose)FDA LinkGeneric
12/2022 - 06/2004
5Phospholipids (Phosphatides)FDA LinkGeneric
01/2022 - 08/2016
4omega-Chloroacetophenone (Mace)IBA
02/2024 - 10/2020
4Lipoprotein Lipase (Diacylglycerol Lipase)IBA
02/2024 - 11/2005
48- hydroxy- 2,2,14,14- tetramethylpentadecanedioic acidIBA
01/2023 - 01/2019
4Simvastatin (Zocor)FDA LinkGeneric
04/2015 - 12/2002
4Polytetrafluoroethylene (Teflon)FDA Link
09/2005 - 02/2004
3CytokinesIBA
01/2024 - 01/2018
3lipoprotein cholesterolIBA
11/2023 - 10/2007
3evinacumabIBA
11/2023 - 12/2020
3Atorvastatin (Lipitor)FDA Link
11/2023 - 10/2016
3Monoclonal AntibodiesIBA
09/2023 - 01/2020
3Blood Proteins (Serum Proteins)IBA
01/2023 - 11/2004
3Interleukin-6 (Interleukin 6)IBA
01/2022 - 03/2012
3Apolipoproteins E (ApoE)IBA
01/2021 - 04/2015
3CalciumIBA
01/2020 - 03/2012
3Apolipoprotein B-100 (Apo B 100)IBA
01/2019 - 05/2010
3EndotoxinsIBA
01/2018 - 05/2007
3Cholesterol Ester Transfer ProteinsIBA
07/2009 - 09/2005
2InflammasomesIBA
01/2024 - 11/2020
2Proprotein Convertase 9IBA
09/2023 - 01/2019
2InterleukinsIBA
01/2022 - 03/2014
2Chemokine ReceptorsIBA
01/2021 - 03/2018
2Ezetimibe (Zetia)FDA Link
01/2021 - 04/2008
2CER-001IBA
10/2020 - 01/2016
2Butyrates (Butyrate)IBA
01/2020 - 01/2016

Therapy/Procedure

43Therapeutics
04/2024 - 12/2002
4Blood Component Removal (Apheresis)
10/2022 - 10/2014
4Renal Dialysis (Hemodialysis)
07/2009 - 02/2004
3Injections
02/2024 - 01/2014
2Diet Therapy (Therapy, Diet)
02/2024 - 02/2023
2Drug Therapy (Chemotherapy)
11/2023 - 09/2010